Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.
Ben Wylie
Advertisement
Ben Wylie is head of Product Management and Marketing at ChargePoint Technologies.
Articles by Ben Wylie
Through the adoption of single-use technology, drug manufacturers have been able to adapt to the challenges posed by the COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Evolving Aseptic Processing LandscapeAugust 1st 2021
De-Risking Sterile Pharma Manufacture with SUTsNovember 15th 2023
Advertisement
Advertisement
Trending on BioPharm International
1
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
2
Updates on Simtra BioPharma Solutions’ Bloomington Capacity Expansions
3
Amgen’s Dazodalibep Reduces Systemic Disease Activity in Phase 3 Sjögren’s Trial
4
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
5